6505-01-025-8575 ( 75525 , NDC00140-0007-52 , NDC00879-0501-09 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-025-8575 | 6505 | 010258575 | CHLORDIAZEPOXIDE HYDROCHLORIDE A | 2667 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| CQLS | CAPSULE CONTENT FORM | POWDER |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 90.000 |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| 75525 | 04493 | A | 2 | 3 | 6 | 54 | |
| NDC00140-0007-52 | 04493 | A | 2 | 3 | 6 | 54 | |
| NDC00879-0501-09 | 60964 | A | 2 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| 75525 | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
| NDC00140-0007-52 | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
| NDC00879-0501-09 | 60964 | HALSEY DRUG CO INC | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 08/11/1 | P | 3004909135 | 2667 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 90 EA |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | G | BT | Q | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|